Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael Collins who wrote (16)	10/15/1996 10:59:00 AM
From: scaram(o)uche	of 1494

First of all, you need to answer my earlier question. :-) The best, by far, bacteriologist that I've ever worked with is named Mike Collins. Coincidence? This guy could give you crystal clear answers from animal models regarding the protective capacity of monoclonals or of polyclonal preps from human plasma. Sturza..... maybe he's gotten better? I just remember being left with the impression "typical M.D. investment logic". :-) No, I should revisit his newsletter and see if it has improved. I found it to have little meat, little analysis of the bench science. I strongly disagreed with an analysis of one company (Repligen?? American Biogenetic Sciences??...... one of those LJPC-like companies that think you'll be impressed if they send out newsletter evaluations) that was headed down, no question. OK, given that I can't give a specific example, I retract my criticism and indicate that I should revisit his opinions. Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next